Summit Therapeutics Inc. Accounts Payable for the year ending December 31, 2024: USD 4.64 M

Summit Therapeutics Inc. Accounts Payable is USD 4.64 M for the year ending December 31, 2024, a 73.83% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Summit Therapeutics Inc. Accounts Payable for the year ending December 31, 2023 was USD 2.67 M, a 651.27% change year over year.
  • Summit Therapeutics Inc. Accounts Payable for the year ending December 31, 2022 was USD 355.00 K, a -91.88% change year over year.
  • Summit Therapeutics Inc. Accounts Payable for the year ending December 31, 2021 was USD 4.37 M, a -28.76% change year over year.
  • Summit Therapeutics Inc. Accounts Payable for the year ending December 31, 2020 was USD 6.14 M.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities